| Identification | Back Directory | [Name]
Glufosfamide | [CAS]
132682-98-5 | [Synonyms]
D 19575
Glufosfamide
Glufosfamide
(D-19575
β-D-Glucopyranose, 1-[N,N'-bis(2-chloroethyl)phosphorodiamidate]
GLUFOSFAMIDE,B-D-GLUCOPYRANOSE, 1-(N,N'-BIS(2-CHLOROETHYL)PHOSPHORODIAMIDATE)-
(2S,3R,4S,5S,6R)-2-Bis(2-chloroethylamino)phosphoryloxy-6-(hydroxymethyl)oxane-3,4,5-triol | [Molecular Formula]
C10H21Cl2N2O7P | [MDL Number]
MFCD00914610 | [MOL File]
132682-98-5.mol | [Molecular Weight]
383.16 |
| Chemical Properties | Back Directory | [Boiling point ]
569.9±60.0 °C(Predicted) | [density ]
1.56±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Soluble in DMSO | [form ]
Solid | [pka]
12.58±0.70(Predicted) | [color ]
Off-white to light yellow |
| Hazard Information | Back Directory | [Uses]
Glufosfamide is an alkylating cytotoxic agent with increased antitumor selectivity and active transmembrane transport mechanism, that belongs to the oxazaphosphorine class. It is an attractive new agent for cancer therapy in humans. |
|
| Company Name: |
NCE Biomedical Co.,Ltd.
|
| Tel: |
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988 |
| Website: |
www.yuhua99.com/ShowSupplierProductsList15748/0_EN.htm |
|